CytoMed Therapeutics (GDTC) Current Leases (2021 - 2025)

CytoMed Therapeutics has disclosed Current Leases across 4 years of filings, most recently posting $53461.0 for Q4 2025.

• In Q4 2025, Current Leases rose 132.16% year-over-year to $53461.0; the TTM figure through Dec 2025 stood at $53461.0 (up 132.16% YoY), while the FY2025 annual figure was $53461.0, up 132.16% from the prior year.
• Current Leases came in at $53461.0 for Q4 2025 at CytoMed Therapeutics, down from $59267.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $59267.0 in Q2 2025 to a low of $6709.0 in Q4 2022.
• Average Current Leases over 4 years is $31556.6, with a median of $23028.0 recorded in 2024.
• Year-over-year, Current Leases sank 56.2% in 2022 and jumped 132.16% in 2025.
• Over 4 years, Current Leases stood at $15318.0 in 2021, then tumbled by 56.2% to $6709.0 in 2022, then surged by 243.24% to $23028.0 in 2024, then jumped by 132.16% to $53461.0 in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $53461.0 in Q4 2025, $59267.0 in Q2 2025, and $23028.0 in Q4 2024.